Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF7 | Erlotinib | 1 | uM | 10 | 625.00 | 172.23 | 521.00 | 459.25 | 1.1345 | 1.1865 |
| MCF7 | Linsitinib | 19.9526 | uM | 10 | 625.00 | 172.23 | 211.00 | 459.25 | 0.4594 | 0.1543 |
| MCF7 | Erlotinib | 0.031623 | uM | 10 | 625.00 | 172.23 | 485.00 | 459.25 | 1.0561 | 1.0786 |
| MCF7 | 0 | uM | 10 | 625.00 | 172.23 | 434.00 | 459.25 | 0.9450 | 0.9216 | |
| MCF7 | 17-AAG | 3.1623 | uM | 10 | 625.00 | 172.23 | 154.00 | 459.25 | 0.3353 | -0.0760 |
| MCF7 | 0 | uM | 10 | 625.00 | 172.23 | 403.00 | 459.25 | 0.8775 | 0.8236 | |
| MCF7 | 0 | uM | 10 | 625.00 | 172.23 | 376.00 | 459.25 | 0.8187 | 0.7364 | |
| MCF7 | 17-AAG | 10 | uM | 10 | 625.00 | 172.23 | 113.00 | 459.25 | 0.2461 | -0.2576 |
| MCF7 | 17-AAG | 0.0016596 | uM | 10 | 625.00 | 172.23 | 356.00 | 459.25 | 0.7752 | 0.6706 |
| MCF7 | Lapatinib | 0.0033113 | uM | 10 | 625.00 | 172.23 | 399.00 | 459.25 | 0.8688 | 0.8108 |
| MCF7 | Erlotinib | 0.01 | uM | 10 | 625.00 | 172.23 | 593.00 | 459.25 | 1.2912 | 1.3960 |
| MCF7 | 0 | uM | 10 | 625.00 | 172.23 | 804.00 | 459.25 | 1.7507 | 1.9711 | |
| MCF7 | Erlotinib | 3.1623 | uM | 10 | 625.00 | 172.23 | 642.00 | 459.25 | 1.3979 | 1.5342 |
| MCF7 | Lapatinib | 0.0016596 | uM | 10 | 625.00 | 172.23 | 575.00 | 459.25 | 1.2520 | 1.3443 |
| MCF7 | Linsitinib | 1 | uM | 10 | 625.00 | 172.23 | 366.00 | 459.25 | 0.7970 | 0.7036 |
| MCF7 | Lapatinib | 3.1623 | uM | 10 | 625.00 | 172.23 | 702.00 | 459.25 | 1.5286 | 1.6994 |
| MCF7 | Linsitinib | 0.0033113 | uM | 10 | 625.00 | 172.23 | 595.00 | 459.25 | 1.2956 | 1.4017 |
| MCF7 | 17-AAG | 0.31623 | uM | 10 | 625.00 | 172.23 | 186.00 | 459.25 | 0.4050 | 0.0559 |
| MCF7 | 17-AAG | 0.01 | uM | 10 | 625.00 | 172.23 | 428.00 | 459.25 | 0.9320 | 0.9028 |
| MCF7 | Lapatinib | 1 | uM | 10 | 625.00 | 172.23 | 621.00 | 459.25 | 1.3522 | 1.4754 |
| MCF7 | Erlotinib | 0.0033113 | uM | 10 | 625.00 | 172.23 | 482.00 | 459.25 | 1.0495 | 1.0695 |
| MCF7 | Erlotinib | 0.31623 | uM | 10 | 625.00 | 172.23 | 637.00 | 459.25 | 1.3870 | 1.5203 |
| MCF7 | Lapatinib | 0.31623 | uM | 10 | 625.00 | 172.23 | 509.00 | 459.25 | 1.1083 | 1.1508 |
| MCF7 | Erlotinib | 10 | uM | 10 | 625.00 | 172.23 | 382.00 | 459.25 | 0.8318 | 0.7559 |
| MCF7 | Erlotinib | 19.9526 | uM | 10 | 625.00 | 172.23 | 691.00 | 459.25 | 1.5046 | 1.6695 |